3-Antigen staphylococcus aureus vaccine (Pfizer)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug Name3-Antigen staphylococcus aureus vaccine (Pfizer)
Drug Alias Name3-antigen Staphylococcus aureus vaccine (Inhibitex/Pfizer)3-ๆŠ—้‡‘้ป„่‰ฒ่‘ก่„็ƒ่Œ็–ซ่‹— (Inhibitex/Pfizer)Staph vaccine (Inhibitex/Pfizer)Staphylcoccus aureus vaccine (Inhibitex/Pfizer)Staphylococcus aureus vaccine (3-antigen, Pfizer) +[9]ย 
ClassificationVaccines > Biological material > Bacterial vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsStaphylococcal Skin InfectionsStaphylococcal InfectionsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsStaphylococcal Skin InfectionsStaphylococcal InfectionsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A